Health Care

Herantis Pharma’s FDA‑approved Phase 2a design for HER‑096 accelerates Parkinson’s trials, with 50%+ funding secured and a 100‑patient study poised to launch in the U.S.

Santhera’s AGAMREE earns orphan drug and fast‑track status in South Korea, offering a potential first‑in‑market DMD therapy and faster approval for patients.

Pro Medic­us’ $44 M health‑care contract win boosts recurring revenue and shares jump 12 %, underscoring AI‑driven growth in medical imaging software.

Agilent Technologies’ recent Rule 144 sale and conflict‑minerals disclosure highlight its strong market position and commitment to ethical sourcing in life‑sciences tools.

Veeva Quality Cloud adoption by Kindeva boosts manufacturing efficiency, scalability and compliance for life‑sciences, driving Veeva’s growth and market confidence.

Discover how Nuvation Bio, a New York‑based biopharma, is advancing next‑generation oncology drugs to tackle drug resistance and what its latest stock, governance, and investor updates reveal for patients and shareholders.

Intuitive Surgical’s leadership shake‑up: Taylor Patton’s promotion to chief commercial officer boosts da Vinci and Ion growth, while Henry Charlton refines operations, positioning ISRG for aggressive expansion and investor confidence amid market di…

Halozyme’s hyaluronidase platform boosts subcutaneous delivery, sparking durable responses in advanced HNSCC and unlocking new oncology growth opportunities.

VentriPoint Diagnostics transforms 2‑D imaging into 3‑D heart models, boosting diagnostic accuracy and surgical precision for heart disease patients. Discover their innovative tech.

Novartis AG remains a Swiss pharma powerhouse amid market volatility, showcasing strong growth, a robust pipeline, and resilient investor confidence.